Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS
b'Atherosclerosis is a major contributor to increased risk of stroke. Our patient\\u2019s choice, Professor Peter Kelly (University College Dublin, Dublin, Ireland) discusses the evidence base implicating inflammation as a key process in the pathogenesis of atherosclerosis, leading to thromboembolic events. Read the full paper here: http://jnnp.bmj.com/content/89/2/211.\\nHow do you measure disease progression in a highly variable and heterogeneous clinical population, such as amyotrophic lateral sclerosis (ALS)? Can plasma creatinine act as a robust surrogate biomarker in clinical trials? Dr. Ruben P A van Eijk (University Medical Center, Utrecht, The Netherlands) discusses this month\\u2019s editor\\u2019s choice. Read the full paper here: http://jnnp.bmj.com/content/89/2/156.'